The Chronic Lower Back Pain Market is set to witness immense growth during the forecast period 2022-2028. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/players/vendors analysis, segments & sub-segments, and forecast. The report also focuses on market drivers, challenges (current and future), revenue growth, future roadmap, standardization, deployment models, and forecast analysis.
Overview:
Some people are suffering from degenerative arthritis, which is the gradual loss of bone density, leaving bones brittle and porous. Others may have a condition called spondylolisthesis, which causes vertebral bodies to slide forward. Other conditions that can cause back pain include infection in the spine, kidney stones, or the pelvis. A recent injury or a neurological problem may also be a cause. The diagnosis can be complicated, though. A backache can be the result of a number of different causes, including a poor sleeping position or a mattress. It can also be a sign of infection or maybe the result of spinal disc problems. In severe cases, the pain may radiate to other parts of the body. If left untreated, it may become chronic and even lead to permanent damage to the spine. Despite its common causes, back pain can be a serious problem that affects the daily routine.
The global chronic lower back pain market focuses on six regions, such as North America, Asia Pacific, South America, Europe, the Middle East, and Africa.
Drivers:
The increasing incidence of back pain-related issues in the world is expected to fuel the growth of the global chronic lower back pain market over the forecast period. For instance, according to the International Association for the Study of Pain, around 577 million individuals in the world suffer from back pain. Back pain is a very common medical condition in the world. It can occur in different ways, from a dull constant ache to sudden, intense pain. Back pain may be caused by a strained muscle, pinched nerve, or disc that has moved out of place. Discs are cushions between vertebrae. Some causes of back pain include osteoporosis, a disease that results in fractured bones. Some pain may even radiate to the arm or leg. Moreover, the high prevalence of the geriatric population in the world is estimated to enhance the growth of the global chronic lower back pain market
Restraints:
Reluctance in diagnosing or treating chronic pain conditions is expected to hinder the growth of the global chronic lower back pain market.
Regional Insights:
In regions, North America is expected to hold a major share of the global chronic lower back pain market, owing to the increasing incidence of back pain issues among individuals in the region. For instance, according to Georgetown University, around 65 million Americans suffer from back pain. Moreover, the Asia Pacific is estimated to witness significant growth in the global chronic lower back pain market owing to the increasing prevalence of the geriatric population in the region.
Competitive Section:
Key players in the global chronic lower back pain market include Teva Pharmaceutical Industries Ltd., CELGENE CORPORATION, SpineThera Inc., Astellas Pharma Inc., Koninklijke Philips N.V., BioWave Corporation, Boston Scientific Corporation, Medtronic, Vertebral Technologies, Inc., Dr. Reddy’s Laboratories Ltd., Merck & Co Inc., Endo Pharmaceuticals Inc., Sanofi, Johnson & Johnson Private Limited, and Pfizer Inc.
Chronic Lower Back Pain Market Dynamics:
This market study estimates the market size in terms of both value (million USD) and volume (K Units). The Chronic Lower Back Pain Market report analyses market trends based on historical data and the latest developments. It provides both qualitative and quantitative data on the elements that will shape the market's growth from 2022 to 2028. The market capacity and consumption potential of major companies are discussed in this research report. Furthermore, it concentrates on prominent regions (Latin America, Europe, Asia Pacific, Africa, and the Middle East). Also, the report evaluates COVID-19's impact on the Chronic Lower Back Pain Market.
Companies profiled in the Chronic Lower Back Pain Market report include:
- Johnson & Johnson Services Inc.
- Pfizer Inc.
- Sanofi
- Endo Pharmaceuticals Inc.
- Merck & Co. Inc.
- Vertebral Technologies Inc.
- Medtronic
- Boston Scientific Corporation
- Bio Wave Corporation
- Koninklijke Philips N.V.
The report covers extensive competitive intelligence which includes the following data points:
⇨ Business Overview
⇨ Business Model
⇨ Financial Data
⇨ Financial – Existing
⇨ Financial – Funding
⇨ Product/Service Segment Analysis and specification
⇨ Recent Development and Company Strategy Analysis
⇨ SWOT Analysis
Segmentation by Type:
The type segment contributed the largest share to the Chronic Lower Back Pain Market in 2021; this segment is projected to grow at the highest CAGR from 2022 to 2028.
- Diskogenic Pain
- Lumbar Spinal Stenosis
- Sacroiliac Pain
- Facet-Joint Pain
- Others
Segmentation by Application:
An end-use industry is projected to grow at the highest CAGR during the forecast period, due to rapid development in emerging economies North America, APAC, MEA, Europe, and ROW.
- Clinical History
- Physical Examination
- Imaging Guidelines
- Assessment of Pain
Key Benefits for Stakeholders:
- The study represents a quantitative analysis of the present Chronic Lower Back Pain Market trends, estimations, and dynamics of the market size from 2022 to 2028 to determine the most promising opportunities.
- Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
- In-depth analysis, as well as market size and segmentation, help you identify current Chronic Lower Back Pain Market opportunities.
- The largest countries in each region are mapped according to their revenue contribution to the market.
- The Chronic Lower Back Pain Market research report gives a thorough analysis of the current status of the Chronic Lower Back Pain Market's major players.
Reasons to Purchase Chronic Lower Back Pain Market Report:
- Both current and future prospects for the Chronic Lower Back Pain Market in developed and emerging markets.
- Analysis of various perspectives of the market with the help of Porter’s five forces analysis.
- During the forecast period, major regions are expected to see the most rapid increase.
- Identify the most recent advancements, Chronic Lower Back Pain Market shares, and top market players' strategies.
Research Methodology:
To estimate and validate the size of the Chronic Lower Back Pain Market and many other dependent submarkets in the overall market, both top-down and bottom-up methodologies are utilized. Key players in the market have been identified through secondary research and their market shares have been determined through primary and secondary research. Secondary sources and verified primary sources were used to determine all percentage share splits and breakdowns.
Request Discount 
Inquire Before Buy
